An Anti-BCMA RNA Aptamer for miRNA Intracellular Delivery
B cell maturation antigen is highly expressed on malignant plasma cells in human multiple myeloma and has recently emerged as a very promising target for therapeutic interventions. Nucleic-acid-based aptamers are small oligonucleotides with high selective targeting properties and functional advantag...
Main Authors: | Silvia Catuogno, Maria Teresa Di Martino, Silvia Nuzzo, Carla Lucia Esposito, Pierfrancesco Tassone, Vittorio de Franciscis |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-12-01
|
Series: | Molecular Therapy: Nucleic Acids |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2162253119303312 |
Similar Items
-
Aptamer-Mediated Targeted Delivery of Therapeutics: An Update
by: Silvia Catuogno, et al.
Published: (2016-11-01) -
STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma
by: Carla Lucia Esposito, et al.
Published: (2018-03-01) -
Aptamer-miRNA-212 Conjugate Sensitizes NSCLC Cells to TRAIL
by: Margherita Iaboni, et al.
Published: (2016-01-01) -
Aptamer Chimeras for Therapeutic Delivery: The Challenging Perspectives
by: Carla Lucia Esposito, et al.
Published: (2018-10-01) -
Identification of a novel RNA aptamer that selectively targets breast cancer exosomes
by: Carla Lucia Esposito, et al.
Published: (2021-03-01)